Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Joanna_Shields
|
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:focus |
pharmaceutical research
AI-driven drug discovery |
| gptkbp:foundedYear |
2013
|
| gptkbp:founder |
gptkb:Ken_Mulvany
|
| gptkbp:headquartersLocation |
gptkb:London
|
| https://www.w3.org/2000/01/rdf-schema#label |
BenevolentAI
|
| gptkbp:industry |
gptkb:artificial_intelligence
drug discovery |
| gptkbp:notableAchievement |
used AI to identify potential drugs for COVID-19
|
| gptkbp:numberOfEmployees |
200+
|
| gptkbp:partner |
gptkb:AstraZeneca
gptkb:Novartis gptkb:Astellas_Pharma |
| gptkbp:stockExchange |
gptkb:Euronext_Amsterdam
|
| gptkbp:stockSymbol |
gptkb:BAI
|
| gptkbp:technology |
gptkb:machine_learning
gptkb:knowledge_representation |
| gptkbp:website |
https://www.benevolent.com/
|
| gptkbp:bfsParent |
gptkb:Wellcome_Trust_Sanger_Institute
|
| gptkbp:bfsLayer |
5
|